Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results

被引:30
作者
Ownby, HE
Korelitz, JJ
Busch, MP
Williams, AE
Kleinman, SH
Gilcher, RO
Nourjah, P
Nass, CC
Waxman, DA
Garratty, G
Hutching, S
Smith, JW
Schreiber, GB
Thomson, RA
Nemo, GJ
Zuck, TF
机构
[1] WESTAT CORP,ROCKVILLE,MD
[2] IRWIN MEM BLOOD CTR,SAN FRANCISCO,CA
[3] AMER RED CROSS,JEROME H HOLLAND LAB,ROCKVILLE,MD
[4] OKLAHOMA BLOOD INST,OKLAHOMA CITY,OK
关键词
D O I
10.1046/j.1537-2995.1997.37297203524.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Blood donors who test repeatably reactive on enzyme immunoassay (EIA) and are not confirmed as positive are a continuing problem for blood banks. Units are discarded and donors are deferred, in spite of multiple studies indicating that such donors are very rarely infected with the transmissible agents. Few data are available, however, with which to evaluate whether the discarded units are more likely to come from particular demographic subgroups. STUDY DESIGN AND METHODS: The Retrovirus Epidemiology Donor Study database of over 2 million allogeneic whole-blood donations collected in the years 1991 through 1993 was utilized. The prevalence of false-positive and indeterminate test results within demographic subgroups was computed for antibodies to human immunodeficiency virus, hepatitis C virus, and human T-lymphotropic virus (anti-HIV, anti-HCV, anti-HTLV, respectively) and hepatitis B surface antigen (false-positive only) as the proportion of donations that were repeatably reactive on EIA but negative or indeterminate on the confirmatory or supplemental test. RESULTS: Several demographic groups with increased prevalence of false-positive and indeterminate anti-HIV results were the same females, younger age groups, blacks, and first-time donors. Likewise, many of the demographic subgroups with increased prevalence of false-positive and indeterminate anti-HCV results were similar: older age groups, non-whites, lower education levels, first-time donors, donors making directed donations, and donors who had received transfusions. For anti-HTLV, by contrast, the oldest group had the highest prevalence of false-positive results but the lowest prevalence of indeterminate results: blacks had the lowest prevalence of false positive results but the highest prevalence of indeterminate results. CONCLUSION: If units that test repeatably reactive on EIA but that are not confirmed as positive are almost always from individuals not infected with the virus in question, then these results indicate that there may be sex-, race-, and/or age-linked proteins cross-reacting with the test kit materials. Elucidation of these antigenic determinants and their subsequent removal should be a priority.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 32 条
[1]   HUMAN LYMPHOTROPIC-T VIRUS TYPE-I ANTIBODY PATTERNS - EVIDENCE OF DIFFERENCE BY AGE AND RISK GROUP [J].
AGIUS, G ;
BIGGAR, RJ ;
ALEXANDER, SS ;
WATERS, DJ ;
DRUMMOND, JE ;
MURPHY, EL ;
WEISS, SH ;
LEVINE, PH ;
BLATTNER, WA .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) :1235-1244
[2]   MULTIPLE UNCONFIRMED-REACTIVE SCREENING-TESTS FOR VIRAL ANTIBODIES AMONG BLOOD-DONORS [J].
BUFFINGTON, J ;
SHAPIRO, CN ;
HOLMAN, RC ;
STRINE, TW ;
GROSSMAN, BJ ;
WILLIAMS, AE ;
ALTER, MJ ;
SCHONBERGER, LB .
TRANSFUSION, 1994, 34 (05) :371-375
[3]   Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors [J].
Busch, MP ;
Kleinman, SH ;
Williams, AE ;
Smith, JW ;
Ownby, HE ;
Laycock, ME ;
Lee, LLL ;
Pau, CP ;
Schreiber, GB .
TRANSFUSION, 1996, 36 (01) :37-44
[4]   INDETERMINATE REACTORS TO TESTS FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV) [J].
CALABRESE, LH .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (01) :95-95
[5]   INDETERMINATE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WESTERN BLOTS - SEROCONVERSION RISK, SPECIFICITY OF SUPPLEMENTAL TESTS, AND AN ALGORITHM FOR EVALUATION [J].
CELUM, CL ;
COOMBS, RW ;
LAFFERTY, W ;
INUI, TS ;
LOUIE, PH ;
GATES, CA ;
MCCREEDY, BJ ;
EGAN, R ;
GROVE, T ;
ALEXANDER, S ;
KOEPSELL, T ;
WEISS, N ;
FISHER, L ;
COREY, L ;
HOLMES, KK .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (04) :656-664
[6]   RISK-FACTORS FOR REPEATEDLY REACTIVE HIV-1 EIA AND INDETERMINATE WESTERN BLOTS - A POPULATION-BASED CASE-CONTROL STUDY [J].
CELUM, CL ;
COOMBS, RW ;
JONES, M ;
MURPHY, V ;
FISHER, L ;
GRANT, C ;
COREY, L ;
INUI, T ;
WENER, MH ;
HOLMES, KK .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (10) :1129-1137
[7]   THE SPECIFICITY OF ENZYME IMMUNOASSAYS FOR ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS - IMPACT ON RECORD AND DONOR MANAGEMENT [J].
DODD, RY ;
HOULIHAN, K ;
LAMBERSON, HV .
TRANSFUSION, 1993, 33 (08) :693-693
[8]   RESOLUTION OF INFECTION STATUS OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-SEROINDETERMINATE DONORS AND HIGH-RISK SERONEGATIVE INDIVIDUALS WITH POLYMERASE CHAIN-REACTION AND VIRUS CULTURE - ABSENCE OF PERSISTENT SILENT HIV TYPE-1 INFECTION IN A HIGH-PREVALENCE AREA [J].
EBLE, BE ;
BUSCH, MP ;
KHAYAMBASHI, H ;
NASON, MA ;
SAMSON, S ;
VYAS, GN .
TRANSFUSION, 1992, 32 (06) :503-508
[9]  
FANG C, 1993, TRANSFUSION, V33, pS37
[10]  
GENESCA J, 1989, LANCET, V2, P1023